Life-Saving Drug Denied: Cancer Patient Faces £200K Bill Due to NHS Criteria

Sarah Barchetti, a 50-year-old mum from Alkrington, Middleton, first received a life-altering diagnosis of breast cancer in June 2015. She had initially gone to the doctors alone after noticing a thickening of the skin around her breasts, convinced it was nothing serious. However, the immediate concern on the medical staff's faces quickly revealed the gravity of her situation, leading to a biopsy, mammogram, and a formal diagnosis.

Her life took a whirlwind turn, with intensive treatment commencing rapidly. By July 2015, she began 'horrific' chemotherapy at The Christie, followed a few weeks later by radiotherapy. Remarkably, by January of the following year, Sarah was declared clear of cancer, allowing her to celebrate her 40th birthday with a surprise party that also marked the end of a challenging chapter. Life, for a while, returned to a semblance of normalcy as she resumed work and holidays, believing the ordeal was behind her.

However, early in 2019, Sarah began feeling unwell again, a persistent feeling she couldn't pinpoint. Upon returning from a trip to London, she immediately sought medical attention. Scans delivered the devastating news: she had incurable secondary breast cancer, meaning the disease had spread to other parts of her body. Despite being told to prepare for the worst, Sarah has defied expectations, remarkably surviving seven years with the condition, outliving the typical prognosis of two to three years.

Over the past 11 years, Sarah's battle has been gruelling, involving eight rounds of chemotherapy, numerous surgeries and biopsies, additional radiotherapy, and various drug courses. Throughout this arduous journey, her daughter, now 14, has been her unwavering focus and source of strength. She credits her strong mind for helping her body endure the treatments, stating that she continued to fight for her daughter, recognizing that for her, any other option was simply not an option.

A recent and critical turn in Sarah's story has emerged: doctors have confirmed that chemotherapy is no longer effective, and all available NHS treatment options have been exhausted. There is, however, a promising drug on the market for patients with her type of cancer, which could extend her life by several months and stabilize her condition, potentially allowing her to re-enter a trial list for new drugs. Unfortunately, Sarah does not meet the NHS eligibility criteria for this treatment, describing herself as a victim of a